Trial Profile
A Phase I Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jul 2023
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Topotecan (Primary)
- Indications Cervical cancer
- Focus Adverse reactions
- 09 Jun 2010 Actual end date (1 Dec 2009) added as reported by ClinicalTrials.gov.
- 09 Jun 2010 Actual patient number (18) added as reported by ClinicalTrials.gov.
- 09 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.